Advertisement
Screener

KRAIG BIOCRAFT LABORATORIES, INC. (KBLB) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

KRAIG BIOCRAFT LABORATORIES, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

KRAIG BIOCRAFT LABORATORIES, INC. (KBLB) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $0.08 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-08-13

  • KRAIG BIOCRAFT LABORATORIES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2026-03-31 was $0.08.
  • KRAIG BIOCRAFT LABORATORIES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2014-03-31 was $0.00.
  • KRAIG BIOCRAFT LABORATORIES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $0.09.
  • KRAIG BIOCRAFT LABORATORIES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2021 was $0.13.
  • KRAIG BIOCRAFT LABORATORIES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
  • KRAIG BIOCRAFT LABORATORIES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2017 was $0.03.
Period endShare-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 monthShare-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 monthShare-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 monthShare-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month
2026-06-30$0.08
10-Q · filed 2026-08-13
2026-03-31$0.08
10-Q · filed 2026-05-14
2025-12-31$0.09
POS AM · filed 2026-05-11
2024-12-31$0.09
10-K · filed 2025-03-28
2021-12-31$0.13
10-K · filed 2023-03-29
2019-09-30$0.00
10-Q · filed 2019-11-13
2019-06-30$0.00
10-Q · filed 2019-08-12
2018-12-31$0.00
10-K · filed 2019-03-29
2018-09-30$0.00
10-Q · filed 2018-11-13
2017-12-31$0.03
10-K · filed 2018-03-23
2017-09-30$0.03
10-Q · filed 2017-11-15
2017-06-30$0.03
10-Q · filed 2017-08-14
2016-06-30$0.00
10-Q · filed 2016-08-12
2015-12-31$0.00
10-Q · filed 2016-08-12
2015-09-30$0.00
10-Q · filed 2015-11-05
2015-06-30$0.00
10-Q · filed 2015-08-11
2014-12-31$0.00
10-K · filed 2015-03-31
2014-09-30$0.00
10-Q · filed 2014-10-23
2014-06-30$0.00
10-Q · filed 2014-08-14
2014-03-31$0.00
10-Q · filed 2014-05-15
2013-12-31$0.00
10-Q · filed 2014-10-23
2013-09-30$0.00
10-Q · filed 2013-11-19
2012-12-31$0.00
10-Q · filed 2014-10-23